Vincent Medical Holdings Limited (HK:1612)
:1612
Want to see HK:1612 full AI Analyst Report?
1612 Stock Chart & Stats
HK$0.83
<HK$0.01(1.28%)
At close: 4:00 PM EST
HK$0.83
<HK$0.01(1.28%)
Day’s Range― - ―
52-Week RangeHK$0.39 - HK$1.32
Previous CloseN/A
Volume194.00K
Average Volume (3M)785.93K
Market Cap
HK$553.90M
Enterprise ValueHK$472.04M
Total Cash (Recent Filing)HK$250.87M
Total Debt (Recent Filing)HK$177.42M
Price to Earnings (P/E)5.1
Beta0.65
Next Earnings
Aug 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.94%
Share Statistics
EPS (TTM)0.16
Shares Outstanding659,399,840
10 Day Avg. Volume481,400
30 Day Avg. Volume785,933
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)0.81
Price to Sales (P/S)0.57
P/FCF Ratio9.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.12
Revenue Forecast (FY)HK$1.17B
Bulls Say, Bears Say
Bulls Say
Improving ProfitabilityThe company regained profitability after 2022, with materially wider gross and net margins in 2025. Sustained margin expansion and improved ROE indicate stronger pricing, product mix and cost control, supporting durable earnings power if trends continue.
Focused Respiratory-device Franchise And ChannelsConcentrated product focus on respiratory and anesthesia devices sold through direct and distributor B2B channels provides structural demand from hospitals and ICUs. Institutional procurement and recurring consumable sales create steady revenue baselines and channel diversification benefits.
Manageable Leverage And Stronger Capital BaseLeverage remains modest at ~0.27 D/E and equity has expanded since earlier years, while ROE improved to ~16% in 2025. That balance-sheet position supports investment, tender participation and dividend capacity relative to peers, preserving medium‑term financial flexibility.
Bears Say
Weak Free Cash Flow ConversionFree cash flow converts only about one‑third of accounting earnings, limiting internal funding for capex, R&D and working capital needs. The volatility of cash generation increases reliance on external financing and constrains predictable reinvestment and shareholder returns.
Earnings Volatility And Prior Loss YearHistoric swings — strong in 2020, weak in 2021–2022 and uneven recovery since — suggest earnings are not yet steady-state. For a tender-driven medical supplier, this cyclical volatility compounds planning risk, making forecasting, capacity choices and long-term contracts harder.
Rising Debt TrendAn upward drift in leverage over recent years reduces the company’s balance-sheet conservatism. Higher indebtedness increases interest and refinancing risk, and narrows maneuvering room to absorb slower tender wins or fund growth without raising costlier capital.
Vincent Medical Holdings Limited News
1612 FAQ
What was Vincent Medical Holdings Limited’s price range in the past 12 months?
Vincent Medical Holdings Limited lowest stock price was HK$0.39 and its highest was HK$1.32 in the past 12 months.
What is Vincent Medical Holdings Limited’s market cap?
Vincent Medical Holdings Limited’s market cap is HK$553.90M.
When is Vincent Medical Holdings Limited’s upcoming earnings report date?
Vincent Medical Holdings Limited’s upcoming earnings report date is Aug 26, 2026 which is in 95 days.
How were Vincent Medical Holdings Limited’s earnings last quarter?
Vincent Medical Holdings Limited released its earnings results on Mar 25, 2026. The company reported HK$0.082 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.082.
Is Vincent Medical Holdings Limited overvalued?
According to Wall Street analysts Vincent Medical Holdings Limited’s price is currently Overvalued.
Does Vincent Medical Holdings Limited pay dividends?
Vincent Medical Holdings Limited pays a Quarterly dividend of HK$0.024 which represents an annual dividend yield of 4.94%. See more information on Vincent Medical Holdings Limited dividends here
What is Vincent Medical Holdings Limited’s EPS estimate?
Vincent Medical Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vincent Medical Holdings Limited have?
Vincent Medical Holdings Limited has 659,399,840 shares outstanding.
What happened to Vincent Medical Holdings Limited’s price movement after its last earnings report?
Vincent Medical Holdings Limited reported an EPS of HK$0.082 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.075%.
Which hedge fund is a major shareholder of Vincent Medical Holdings Limited?
Currently, no hedge funds are holding shares in HK:1612
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vincent Medical Holdings Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
116.00%
12-Months-Change
Fundamentals
Return on Equity
16.21%
Trailing 12-Months
Asset Growth
27.38%
Trailing 12-Months
Company Description
Vincent Medical Holdings Limited
Vincent Medical Holdings Limited, an investment holding company, researches, develops, manufactures, markets, and sells medical devices. It operates in two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing. The company develops medical devices focusing on respiratory products; imaging contrast media power injector disposables; and orthopedic and rehabilitation products for OEM customers. Its respiratory products portfolio includes humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, and anesthesia systems. The company's orthopedic and rehabilitation products comprise various adjustable rehabilitation braces for support and protection, and rehabilitation of various skeletomuscular parts after injury or surgery. It also develops robotic hand training devices. Vincent Medical Holdings Limited sells its products under the Inspired Medical, Hand of Hope, and Hypnus brand names in the People's Republic of China, the United States, the Netherlands, Australia, Japan, and internationally. The company was founded in 1997 and is headquartered in Hung Hom, Hong Kong. Vincent Medical Holdings Limited is a subsidiary of Vincent Raya International Limited.
Technical Analysis
Peijia Medical Ltd.
―
Acotec Scientific Holdings Limited
―
AK Medical Holdings Ltd.
―
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
―
MicroPort NeuroTech Limited
―